ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

Original reporting
Published Aug 6, 2026, 3:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 3:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL (ICL) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ICLNeutralMed
01

Why it matters

The most tradable elements are the reiterated 2026 EBITDA range, quantified Elevate savings mix, and explicit margin risks from elevated sulfur and freight plus Brazil softness. These directly inform forward margin and cash-flow expectations.

02

Market read

Q2 profitability and cash flow improved, but management flagged continued second-half margin pressure from sulfur and freight, while maintaining the 2026 EBITDA outlook.

03

What to watch

The call emphasizes sulfur and freight risks, but also cites production efficiency gains and segment-specific EBITDA strength (notably Industrial Products). Traders may be underweighting the offsetting volume and pricing improvements versus raw-cost inflation.

Relevance 8/10Novelty 7/10Timing: pre-market today, Aug. 5 call transcript and guidance details

Background

ICL Group’s Q2 2026 earnings call covers segment performance, reiterated full-year EBITDA guidance, and a multiyear cost transformation program (Elevate) with reporting reorganization effective Q1 2027.

Company-level read

Ticker impact

$ICLNeutralMedium confidence
Context

ICL reported Q2 2026 sales of $2.1B, reiterated 2026 EBITDA guidance of $1.5B to $1.7B, and outlined the Elevate cost program through 2028.

Expected impact

Moderate volatility risk around margin expectations, with upside bias if sulfur/freight normalize and downside if they stay elevated.

Evidence & confidence

The call provides multiple decision-relevant datapoints: segment EBITDA growth, FCF improvement, leverage staying at 1.5x, and explicit risk commentary on sulfur and Brazil softness. However, the full-year EBITDA range is reiterated, limiting incremental surprise versus prior expectations.

Market effects

Fertilizer and industrial chemicals traders may reprice potash, phosphate, and bromine margin sensitivity to sulfur and freight, using ICL’s quantified headwinds.

Brazil softness commentary can influence sentiment for fertilizer demand and specialty fertilizer pricing in Brazil-linked exposures.

Freight disruption in the Middle East and currency (shekel vs USD) exposure highlight cross-border cost pressures relevant to global commodity supply chains.

Counterpoint

Elevate savings targets (productivity and SG&A optimization) could offset sulfur-driven margin pressure more than the market assumes, supporting a higher earnings floor than the risk framing implies.

Key entities

  • ICL Group Ltd

    Reported Q2 2026 results, reiterated 2026 EBITDA guidance, and detailed Elevate cost transformation and segment reorganization.

  • Elad Aharonson

    CEO who discussed functional food growth targets and ongoing margin risks (including Brazil softness).

  • Asaf Alperovitz

    CFO who quantified sulfur price dynamics and highlighted shekel exposure affecting Israel operations.

Related articles

$ICLMedAI 8/10

ICL Group Ltd (ICL) Q3 2026 Earnings Call Highlights: Industrial Strength and Cost Cuts

ICL Group Ltd reported Q3 2026 earnings, with CEO Elad Aronson and CFO Assaf discussing market outlook, segment performance, and cost management. Key points include stable potash demand, rising phosphate fertilizer demand, and falling sulfur prices. Industrial products sales rose 18% YoY to $347M, with EBITDA up nearly 50%. Potash EBITDA declined 7% YoY due to higher costs. The company expects 2026 EBITDA to be within the $1.5B-$1.7B guidance range, with relief from sulfur costs in 2027.

$ICLMed

ICL Group Ltd Q3 2026 Earnings Call Summary

ICL Group Ltd reported Q3 2026 earnings, highlighting growth from strategic price increases and high-margin products. Key segments showed mixed results: Industrial Products benefited from bromine price increases, Phosphate Solutions saw resilience in specialty products, and Potash margins faced pressure. The company expects 2026 EBITDA of $1.5B-$1.7B and $150M EBITDA improvement in 2027 from cost-cutting.

$ICLMedAI 8/10

ICL Group Q3 Earnings Call Highlights

ICL Group reported Q3 average potash price at $370/ton, up 5% YoY. Phosphate Solutions sales were $589M, EBITDA $118M. Growing Solutions sales were $538M, EBITDA $44M. Sulfur costs rose 220% YoY, impacting Q4. ICL expects $150M EBITDA improvement by 2027. Company to reorganize segments in 2027. Maintained 2026 potash sales forecast of 4.5-4.7M metric tons. Paid $63M dividend in Q3.

$ICLHighAI 8/10

ICL Group (ICL) Q3 2026 Earnings Call Transcript

ICL Group reported Q3 2026 adjusted net income of $126M, up 2%, with EPS at $0.10. Operating cash flow was $256M, and free cash flow was $66M. Industrial Products sales rose 18% YoY, driven by higher bromine prices. Potash sales increased 4% YoY, but EBITDA fell 7% due to cost pressures. Phosphate Solutions sales were $589M with a 20% EBITDA margin, despite higher raw material costs. Growing Solutions sales were $538M with EBITDA of $44M, facing market challenges in Brazil.